ABVC BIOPHARMA, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Abvc Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Abvc Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $508K, a 43.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $508K -$392K -43.6% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $607K -$393K -39.3% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $708K -$391K -35.6% Mar 31, 2024 10-Q 2024-05-17
Q4 2023 $809K -$352K -30.3% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $900K -$344K -27.7% Sep 30, 2023 10-Q 2023-11-15
Q2 2023 $1M -$295K -22.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.1M -$284K -20.5% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1.16M -$311K -21.1% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $1.24M -$310K -20% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.29M -$342K -20.9% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.38M -$332K -19.4% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.47M -$301K -17% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $1.55M -$289K -15.7% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.64M +$1.25M +327% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.71M +$1.27M +281% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $1.77M +$1.25M +238% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $1.84M +$1.49M +415% Sep 30, 2020 10-Q 2020-11-17
Q2 2020 $383K -$48.3K -11.2% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $450K -$55.6K -11% Mar 31, 2020 10-Q 2020-06-30
Q4 2019 $524K Dec 31, 2019 10-K 2021-03-16
Q3 2019 $358K Sep 30, 2019 10-Q 2019-11-18
Q2 2019 $431K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $505K Mar 31, 2019 10-Q 2019-05-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.